Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Response to Liu and Zhang

Rong Xu1

  • 1Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, OH, United States.

Journal of the National Cancer Institute
|December 10, 2024
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Swarm Intelligence in Drug Discovery Applications: Unlocking Deeper Insights on the Identification and Optimization of Potential Drug Candidates.

Drug design, development and therapy·2026
Same author

Age-related macular degeneration and dementia: Association through pathogenesis or visual impairment?

Journal of Alzheimer's disease : JAD·2026
Same author

Comparative evaluation of large language models in retrieving known and predicting novel drug combinations.

Journal of Alzheimer's disease : JAD·2026
Same author

Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis.

Nature communications·2025
Same author

Potential Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Diabetes and High Risk for Dementia.

Annals of internal medicine·2025
Same author

Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.

Journal of Alzheimer's disease : JAD·2025